Antibody profiling in plague patients by protein microarray

Microbes and Infection

Volumn 10, Issue 1, 2008, Pages 45-51

  Li, Bei ^a   Zhou, Dongsheng ^a   Wang, Zuyun ^b   Song, Zhizhong ^c   Wang, Hu ^b   Li, Min ^b   Dong, Xingqi ^c   Wu, Mingshou ^c   Guo, Zhaobiao ^a   Yang, Ruifu ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Qinghai Institute for Endemic Disease Prevention and Control   (China)

^c Yunnan Institute for Epidemic Diseases Control and Research   (China)

Author keywords

Antibody profile; Protein microarray; Yersinia pestis

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; STREPTOMYCIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SERODIAGNOSIS; YERSINIA PESTIS;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLAGUE; PROTEIN ARRAY ANALYSIS; YERSINIA PESTIS;

YERSINIA PESTIS;

EID: 39149129344     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.10.003     Document Type: Article

References (30)

1. Perry R.D., and Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clin. Microbiol. Rev. 10 (1997) 35-66
2. WHO. Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 45 (1996) 1-15
3. Guiyoule A., Gerbaud G., Buchrieser C., Galimand M., Rahalison L., Chanteau S., Courvalin P., and Carniel E. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg. Infect. Dis. 7 (2001) 43-48
4. Inglesby T.V., Dennis D.T., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Friedlander A.M., Hauer J., Koerner J.F., Layton M., McDade J., Osterholm M.T., O'Toole T., Parker G., Perl T.M., Russell P.K., Schoch-Spana M., and Tonat K. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Jama 283 (2000) 2281-2290
5. Titball R.W., and Williamson E.D. Vaccination against bubonic and pneumonic plague. Vaccine 19 (2001) 4175-4184
6. Williamson E.D., Eley S.M., Griffin K.F., Green M., Russell P., Leary S.E., Oyston P.C., Easterbrook T., Reddin K.M., Robinson A., et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 12 (1995) 223-230
7. Grosfeld H., Bino T., Flashner Y., Ber R., Mamroud E., Lustig S., Velan B., Shafferman A., and Cohen S. Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague. Adv. Exp. Med. Biol. 529 (2003) 423-424
8. Matson J.S., Durick K.A., Bradley D.S., and Nilles M.L. Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiol. 5 (2005) 38
9. Titball R.W., and Williamson E.D. Yersinia pestis (plague) vaccines. Expert. Opin. Biol. Ther. 4 (2004) 965-973
10. Li B., Jiang L., Song Q., Yang J., Chen Z., Guo Z., Zhou D., Du Z., Song Y., Wang J., Wang H., Yu S., and Yang R. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine. Infect. Immun. 73 (2005) 3734-3739
11. Zhou D., Han Y., Song Y., Huang P., and Yang R. Comparative and evolutionary genomics of Yersinia pestis. Microbes Infect. 6 (2004) 1226-1234
12. Mezzasoma L., Bacarese-Hamilton T., Di Cristina M., Rossi R., Bistoni F., and Crisanti A. Antigen microarrays for serodiagnosis of infectious diseases. Clin. Chem. 48 (2002) 121-130
13. Parkhill J., Wren B.W., Thomson N.R., Titball R.W., Holden M.T., Prentice M.B., Sebaihia M., James K.D., Churcher C., Mungall K.L., Baker S., Basham D., Bentley S.D., Brooks K., Cerdeno-Tarraga A.M., Chillingworth T., Cronin A., Davies R.M., Davis P., Dougan G., Feltwell T., Hamlin N., Holroyd S., Jagels K., Karlyshev A.V., Leather S., Moule S., Oyston P.C., Quail M., Rutherford K., Simmonds M., Skelton J., Stevens K., Whitehead S., and Barrell B.G. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413 (2001) 523-527
14. Leary S.E., Griffin K.F., Galyov E.E., Hewer J., Williamson E.D., Holmstrom A., Forsberg A., and Titball R.W. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague. Microb. Pathog. 26 (1999) 159-169
15. Benner G.E., Andrews G.P., Byrne W.R., Strachan S.D., Sample A.K., Heath D.G., and Friedlander A.M. Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. Infect. Immun. 67 (1999) 1922-1928
16. Zhang G., Zhang J., and Wang R. Survey of natural focuses of Plague and epidemic situations in China (in Chinese). Chin. J. Ctrl. Endem. Dis. 17 (2002) 101-103
17. Ji S., He J., Teng Y., Zhan X., Lei C., Wang W., et al. The discovery and research of plague natural foci in China (in Chinese). Chi. J. Epidemiol. 11 Suppl (1990) 1-41
18. Cornelis G.R. Molecular and cell biology aspects of plague. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 8778-8783
19. Sodhi A., Sharma R.K., Batra H.V., and Tuteja U. Mechanism of rLcrV and rYopB mediated immunosuppression in murine peritoneal macrophages. Mol. Immunol. 41 (2004) 767-774
20. Mueller C.A., Broz P., Muller S.A., Ringler P., Erne-Brand F., Sorg I., Kuhn M., Engel A., and Cornelis G.R. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310 (2005) 674-676
21. Rocke T.E., Mencher J., Smith S.R., Friedlander A.M., Andrews G.P., and Baeten L.A. Recombinant F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against virulent Yersinia pestis infection. J. Zoo Wildl. Med. 35 (2004) 142-146
22. Williamson E.D., Flick-Smith H.C., Lebutt C., Rowland C.A., Jones S.M., Waters E.L., Gwyther R.J., Miller J., Packer P.J., and Irving M. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect. Immun. 73 (2005) 3598-3608
23. Russell P., Eley S.M., Hibbs S.E., Manchee R.J., Stagg A.J., and Titball R.W. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13 (1995) 1551-1556
24. Song Y., Tong Z., Wang J., Wang L., Guo Z., Han Y., Zhang J., Pei D., Zhou D., Qin H., Pang X., Zhai J., Li M., Cui B., Qi Z., Jin L., Dai R., Chen F., Li S., Ye C., Du Z., Lin W., Yu J., Yang H., Huang P., and Yang R. Complete genome sequence of Yersinia pestis strain 91001, an isolate avirulent to humans. DNA Res. 11 (2004) 179-197
25. Zhou D., Tong Z., Song Y., Han Y., Pei D., Pang X., Zhai J., Li M., Cui B., Qi Z., Jin L., Dai R., Du Z., Wang J., Guo Z., Huang P., and Yang R. Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus. J. Bacteriol. 186 (2004) 5147-5152
26. Zhou D., Han Y., Song Y., Tong Z., Wang J., Guo Z., Pei D., Pang X., Zhai J., Li M., Cui B., Qi Z., Jin L., Dai R., Du Z., Bao J., Zhang X., Yu J., Huang P., and Yang R. DNA microarray analysis of genome dynamics in Yersinia pestis: insights into bacterial genome microevolution and niche adaptation. J. Bacteriol. 186 (2004) 5138-5146
27. Chain P.S., Carniel E., Larimer F.W., Lamerdin J., Stoutland P.O., Regala W.M., Georgescu A.M., Vergez L.M., Land M.L., Motin V.L., Brubaker R.R., Fowler J., Hinnebusch J., Marceau M., Medigue C., Simonet M., Chenal-Francisque V., Souza B., Dacheux D., Elliott J.M., Derbise A., Hauser L.J., and Garcia E. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13826-13831
28. Bacarese-Hamilton T., Ardizzoni A., Gray J., and Crisanti A. Protein arrays for serodiagnosis of disease. Methods Mol. Biol. 264 (2004) 271-283
29. Li M., Song Y., Li B., Wang Z., Yang R., and Jiang L. Asymptomatic Yersinia pestis infection, China. Emerg. Infect. Dis. 11 (2005) 1494-1496
30. Chen Z., Pei D., Jiang L., Song Y., Wang J., Wang H., Zhou D., Zhai J., Du Z., Li B., Qiu M., Han Y., Guo Z., and Yang R. Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin. Chem. 50 (2004) 988-995